165669-35-2

Usage

Uses

Used in Pharmaceutical Industry:
7-Bromo-1H-pyrrolo[2,3-c]pyridine is used as a building block for the synthesis of various biologically active compounds. Its unique structure and reactivity contribute to the development of potential drugs and agrochemicals, enhancing their therapeutic properties and effectiveness.
Used in Materials Science:
In the field of materials science, 7-Bromo-1H-pyrrolo[2,3-c]pyridine is studied for its potential applications in the development of organic electronic and optoelectronic devices. Its conjugated system and electron-rich nature make it a promising candidate for improving the performance of these devices.

InChI:InChI=1/C7H5BrN2/c8-7-6-5(1-3-9-6)2-4-10-7/h1-4,9H

Upstream product

• 165669-36-3 1H-pyrrolo[2,3-c]pyridine-7-amine 
• 19755-53-4 2-bromo-3-nitropyridine 
• 1826-67-1 vinyl magnesium bromide 

Downstream Products

• 165669-36-3 1H-pyrrolo[2,3-c]pyridine-7-amine 
• 1265023-89-9 7-bromo-1-(4-methoxysulfonyl)-6-azaindole 
• 1265022-42-1 7-phenyl-1-(4-methoxybenzenesulfonyl)-6-azaindole 
• 1265022-24-9 7-anilino-1-(4-methoxybenzenesulfonyl)-6-azaindole 
• 1265022-38-5 7-(4-fluoroanilino)-1-(4-methoxybenzenesulfonyl)-6-azaindole 
• 1265022-58-9 7-(4-hydroxyphenyl)-1-(4-methoxybenzenesulfonyl)-6-azaindole 
• 1265022-62-5 1-(4-methoxybenzenesulfonyl)-7-(4-methoxyphenyl)-6-azaindole 
• 1265022-50-1 7-(4-fluorophenyl)-1-(4-methoxybenzenesulfonyl)-6-azaindole 
• 1265022-66-9 7-(4-(N,N-dimethylaminophenyl))-1-(4-methoxybenzenesulfonyl)-6-azaindole 
• 1265022-54-5 7-(4-chlorophenyl)-1-(4-methoxybenzenesulfonyl)-6-azaindole 
• 1265022-78-3 1-(4-methoxybenzenesulfonyl)-7-(4-trifluoromethylphenyl)-6-azaindole 
• 1265022-74-9 1-(4-methoxybenzenesulfonyl)-7-(4-nitrophenyl)-6-azaindole 
• 1265022-70-5 1-(4-methoxybenzenesulfonyl)-7-(pyridin-4-yl)-6-azaindole 
• 1265022-82-9 7-(2-furanyl)-1-(4-methoxybenzenesulfonyl)-6-azaindole 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS

The present invention provides a heterocyclic compound of formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof or a hydrate thereof, wherein A, A′ B, D, R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising a compound of formula (I) as an active ingredient, methods of production, and methods of use thereof. Particularly, the present invention provides a compound of formula (I) useful for treating or preventing a disease, condition or disorder associated with protein kinases, preferably Janus Kinase family.

Furanylazaindoles: Potent anticancer agents in vitro and in vivo

Preliminary biological data on 7-anilino-6-azaindoles (8-11) suggested that hydrophobic substituents at C7 contribute to enhancement of antiproliferative activity. A novel series of 7-aryl-6-azaindole-1-benzenesulfonamides (12-22) were developed and showe

HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS

The present invention provides a heterocyclic compound of formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof or a hydrate thereof, wherein A, A' B, D, R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising a compound of formula (I) as an active ingredient, methods of production, and methods of use thereof. Particularly, the present invention provides a compound of formula (I) useful for treating or preventing a disease, condition or disorder associated with protein kinases, preferably Janus Kinase family.

ARYL SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS ANTICANCER AGENTS

Aryl substituted sulfonamide compounds of formula (I) are disclosed. Also disclosed is a method for treating cancer with these compounds.

Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives

This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.

Heterobicyclic sulfonamide and sulfonic ester derivatives

Novel heterobicyclic sulfonamide and sulfonic ester derivatives represented by the following general formula(I), which exhibit an antitumor activity and are lowly toxic, and processes for the preparation thereof. A sulfonamide derivative and a sulfonic ester derivative represented by the general formula (I) or a pharmacologically acceptable salt thereof: STR1 wherein A represents a monocyclic or bicyclic aromatic ring which may be substituted; B represents a six-membered unsaturated hydrocarbon ring or a six-membered unsaturated heterocycle containing one nitrogen atom, each of which may be substituted; C represents a five-membered heterocycle containing one or two nitrogen atoms which may be substituted; W represents a single bond or a group represented by formula --CH=CH--; X represents a group represented by formula --N(R1)-- or oxygen; Y represents carbon or nitrogen; Z represents a group represented by formula --N(R2)-- or nitrogen; and R1 and R2 may be the same or different from each other and each represent hydrogen or lower alkyl.